The ShareSoc blog provides news and informal commentary from directors, members and other contributors. Entries reflect the personal views of the authors, which do not necessarily reflect ShareSoc’s formal position. Contributors may hold shares in the companies mentioned. Nothing in this blog should be viewed as financial advice. You may submit comments on blog posts, but ShareSoc reserves the right to remove or edit inappropriate or defamatory submissions.
I have not published a portfolio review for quite a while, as it’s so time consuming to do. However, 2020 was an extraordinary year, so felt I really ought to see what went wrong, what went right and whether there were any lessons to learn.
Before diving into the details, I need to explain my circumstances and investment strategy. I have been a full-time investor since 2004, living off a fixed pool of capital. Therefore, capital preservation whilst generating sufficient return to cover my living costs is crucial. To meet these objectives, I run a highly diverse portfolio, containing different types of assets.
My overall portfolio is split between a SIPP and an ISA, with the bulk being in my SIPP (from which I now draw a monthly income).
The breakdown between asset types and accounts (at the end of 2020) is illustrated in Figure 1:

Figure 1 – Asset Allocation
To explain the non-obvious asset types:
The cash % shown represents cash within the SIPP and ISA accounts. I also hold significant cash outside those accounts, which is earmarked for a house purchase in the relatively near-term. The reason for the relatively high % of cash in my ISA at the year end will become apparent shortly…
Whilst we all like to think that our investment returns depend primarily on our own skill & diligence, luck plays an important part too. I had two important pieces of luck which significantly influenced my returns this year:
My experience of the financial crisis was invaluable: knowing how scary a crashing market could be but also remembering that my best ever investment returns were in the years following the 2008 crash. This does not mean that one can invest indiscriminately: some companies will be permanently impaired, but it was possible to identify businesses that were well placed to survive the impact of the pandemic (or, indeed, to thrive), but which the market had sold off indiscriminately. Keeping a cool head and not panicking are vital.
I did indeed deploy about half of the earmarked cash that I was prepared to invest – and by the end of the year had realised sufficient gains in my ISA, that I could withdraw that cash again (and some extra!). That explains the high cash weighting in the ISA at year end. I intend to leave that cash in the ISA, until I am ready to make my house purchase.
Another piece of good fortune was the timing of the market plunge: around the end of the tax year, meaning that I could use both the 2019/20 and 2020/21 ISA allowances to add cash, if necessary.
Figure 2 shows the total return achieved by each asset type in each account over 2020:

Figure 2 – Total Return Breakdown
This illustrates several interesting things:
How did I obtain that breakdown of performances? I use SharePad and its group portfolio feature to analyse my portfolio performance. Each cell in the table (e.g. SIPP/High Yield) is represented by a “base” portfolio I have set up in SharePad I then use group portfolios to create aggregated portfolios a) for the SIPP and ISA (to match my broker accounts); b) for each asset type, across both accounts. SharePad calculates the total return for each of these base and group portfolios.
Note that the total overall performance is dragged down as it includes (minimal) returns on my cash savings held outside the SIPP and ISA. Conversely, in a negative year that cash element would cushion returns.
Clearly, these returns are not spectacular but I am satisfied to have achieved a decent positive result in a difficult year.
Now let’s drill deeper into each of the asset type portfolios. For each of these I identify the top 3 “contributors” to performance, and the bottom 3 “detractors”, with some commentary on each. I also list all portfolio components (some of which have been sold by year end) and whether they contributed or detracted “+” indicates a contributor and “-” a detractor “++” a strong (but not top 3) contributor and “–” a strong (but not bottom 3) detractor.
For each of the asset type portfolios, I also show a chart that illustrates relative performance over the year, generated by SharePad. The dark green line on each chart shows the portfolio value and the light green line shows the value of the FTSE All Share Total Return index, as a benchmark.
Figure 3 below is the corresponding chart for my combined portfolio of SIPP, ISA and savings:

Figure 3 – Overall Returns
Notably the drawdown in my combined portfolio in March from the start of the year was around 22% vs 36% for the FTSE All Share. That is where the cushioning effect of the cash element comes into play. Pleasingly, as the year progressed, my portfolio increased its positive divergence from the benchmark. Note also that the chart (both for my portfolio and the benchmark) includes the impact of monthly withdrawals from my SIPP.
I also benchmark my SIPP against the performance of the RIT Capital Partners investment trust (RCP). I chose that because it also has a strong focus on capital preservation – and if I can’t beat it, I would be better off just investing in there. Since starting to monitor in 2006, I have outperformed it, so continue to be happy running my own portfolio.
As Fixed Interest only represents 0.6% of the total portfolio (due to limited attractive opportunities), I won’t analyse that asset type.

Figure 4 – High Yield Portfolio Performance
We can see the HY portfolio started the year underperforming the benchmark, but overtook it in the latter part of the year and now appears to be racing away (time will tell whether that continues!).
Top 3 contributors:
My holdings of Somero and K3 are now significantly larger than they were at the start of 2020, as I feel they have further to go.
Bottom 3 detractors:
My mistake with this holding was to underestimate the impact of a change of business model on the company, forced by legislation changes affecting personal injury claims (and especially RTA – Road Traffic Accident – claims). It is usually a red flag when a company is forced to change its business model. I believed, however, that management had a credible plan to overcome this and had a track record of surviving and prospering after other legislative changes in the past. Further I underestimated the impact of Covid on their business, which affected all areas, with folks staying at home during lockdown significantly reducing accidents of all types and hence the need for NAH’s services. I should have recognised the risks and reduced my holding earlier. Instead, I increased it a little in January, as I thought the share price was too low then, but it went on to more than halve from that point.
Other companies held during the year:
| Company | TIDM | Contributor (+)/Detractor (-) | Comment |
|---|---|---|---|
| Ultimate Products | UPGS | ++ | Several trades during the year enhanced returns, as the stock was volatile. |
| RDL Realisation | RDL | ++ | Realisation situation successfully arbed and now sold |
| Doric Nimrod Air III | DNA3 | ++ | Took advantage of excessively low share price, now sold |
| City of London investment Group | CLIG | ++ | One of my largest holdings |
| Hargreaves Services | HSP | + | |
| Direct Line | DLG | + | |
| Sequoia Infrastructure | SEQI | + | Also a large holding |
| Fair Oaks Income | FAIR | – | Currently my largest holding, as recovering strongly from lows and has resumed large dividend payouts |
| Keller | KLR | – | |
| EasyJet | EZJ | – | Sold early in the year, minimising losses. Not tempted to re-enter yet, as I believe it will take quite some time for airlines to recover |

Figure 5 – Real Estate Portfolio Performance
As can be seen in Figure 2 above, real estate was the one asset type that generated negative returns in 2020. Despite that, the above chart shows that the asset type has significantly outperformed the benchmark, both in the long run and over the course of 2020. The March drawdown for this asset type was similar to that of the benchmark.
Top 3 contributors:
Bottom 3 detractors:
Other companies held during the year:
| Company | TIDM | Contributor (+)/Detractor (-) | Comment |
|---|---|---|---|
| Home REIT | HOME | + | Shares bought in IPO |
| Real Estate Credit Investments | RECI | – | Results and outlook over the year look sound, offering 9% yield. I added to my position at depressed prices over the course of the year. Share price has been recovering, but not fully recovered yet, hence a small loss over the year. |
| Persimmon | PSN | – | Dabbled briefly and unsuccessfully in March. Nervous of housebuilders since due to UK economic uncertainty. |
| Watkin Jones | WJG | – | Added to position over the course of the year, though still modest sized. Shares recovering nicely, but not fully recovered yet. Like their business model. |
| PPHE Hotel Group | PPH | — | Having previously taken profits, only had a small position at the start of 2020, and sold out completely in March, with huge uncertainty over the outlook for hotel groups. A loss for me within the year, but a substantial profit since investing in 2016 |
| Crest Nicholson | CRST | — | Started the year with a midsized position, took some profit in January, but then crystallised a major loss in May, as I lost confidence in the housebuilding sector. |

Figure 6 – Natural Resources Portfolio Performance
This chart is a little peculiar, because this portfolio (dark green) suffered significant losses in 2015 and underperformed in 2016-2019, so started the year well behind its benchmark (light green). It also slightly understates performance because two significant holdings are Canadian quoted companies, which can’t be included in SharePad portfolios, so are omitted. Nevertheless, the significant outperformance over the course of 2020 can be clearly seen.
Top 3 contributors:
Bottom 3 detractors (there were only two detractors this year, all other investments producing positive returns):
Other companies held during the year:
| Company | TIDM | Contributor (+)/Detractor (-) | Comment |
|---|---|---|---|
| Ivanhoe Mines | TSX:IVN | ++ | Earlier in the year, I would have liked to hold more of this stock, but AJ Bell won’t allow me to hold it in the SIPP, so can only have an ISA holding. IMO the shares are pretty fully priced now. |
| Blackrock Energy & Resources Income Trust | BERI | + | Traded this quite heavily over the course of the year, with modest results |
| Triplepoint Energy Efficiency Infrastructure | TEEC | + | Subscribed in IPO |
Whilst I used to include oil & gas companies in this portfolio, I no longer do so, as I feel that that industry is now in secular decline.

Figure 7 – International Portfolio Performance
As Figure 2 shows, this portfolio has been a good performer in 2020 and a star within my ISA.
Top 3 contributors:
Bottom 3 detractors. There were only two small detractors in this portfolio:
Other companies held during the year:
| Company | TIDM | Contributor (+)/Detractor (-) | Comment |
|---|---|---|---|
| JP Morgan Global Growth and Income | JGGI | ++ | A solid performer, also producing a good income. Traded successfully in the year, buying on the March dip and selling some at significantly high prices later in the year. Finished the year with more shares than I started with, at negative net cost. |
| JP Morgan Emerging Markets | JMG | ++ | Added to my holding of this outperformer in the March dip and have not sold any shares. |
| Fidelity Asian Values | FAS | ++ | Likewise added to my holding in the March dip and have not sold any shares. |
| Hg Capital Trust | HGT | + | Also added in the March dip but subsequently trimmed this longstanding holding as it moved to a premium to NAV |
| Worldwide Healthcare Trust | WWH | + | Solid performance continues |
| Ocean Wilson | OCN | + | Doubled my position over the course of the year, with opportunities to add at exceptionally low prices in the first half of the year. This company is a strange hybrid of an investment portfolio and a substantial Brazilian quoted ports business. At times in 2020 it was possible to pick up the shares at little more than the value of the investment portfolio, despite the ports business having substantial value on the Bovespa. |
| RIT Capital Partners | RCP | + | I started the year with a CFD short position on this stock (as a hedge) as it was trading at a historically high premium to NAV. As pandemic fears spread, the premium declined and I covered my short. Then as the shares moved to a discount, I bought the shares and as the discount increased opened long CFD positions too. These proved profitable too as RCP performed well. I retain a long CFD position, as well as an ISA holding, as the shares continue to trade at a meaningful discount to NAV. |
| Fundsmith Emerging Equities Trust | FEET | + | I sold this longstanding holding in October, as it was consistently outperformed by JMG |
| Templeton Emerging Markets | TEM | + | New position in December to diversify from JEFI |
| JP Morgan Asia Growth & Income | JAGI | + | Ditto |

Figure 8 – “Other” Portfolio Performance
This chart is distorted by the fact that most of my monthly SIPP income drawdowns are taken from this portfolio. Nevertheless, it clearly shows the outperformance against the benchmark and that the portfolio has maintained its value despite the drawdowns.
Top 3 contributors:
Bottom 3 detractors: No detractors in this portfolio!
Other companies held during the year:
| Company | TIDM | Contributor (+)/Detractor (-) | Comment |
|---|---|---|---|
| RA International | RAI | + | Whilst the company and its shares had a pedestrian performance, I made a useful unrealised gain by topping up @ 36p during the March panic. |
| Judges Scientific | JDG | + | No trades during the year but the company and its shares continued their irresistible rise. |
| Renew Holdings | RNWH | + | Renew’s shares had a bit of a rollercoaster year, finishing slightly below where they started but I took advantage of a big dip in March, banking gains in April and then selling out altogether in December. Renew has been my most profitable single shareholding, having held since 2006 and taking advantage of a distressed share price during the financial crisis. But performance has been uninspiring in recent years and I got fed up by their unwillingness to engage with individual investors. |
| Schroder UK Public Private Trust (fka Woodford Patient Capital) | SUPP | + | A special situation I entered in August, believing that SUPP’s holdings may have bottomed out and the massive discount to NAV may unwind. Only a toe in the water as I wait to see how this evolves (and debt gets repaid). |
| Cranswick | CWK | + | I didn’t trade this high-quality food producer and it gained slightly over the year. |
| Avingtrans | AVG | + | Also no trades and a small gain over the year. Like Cranswick, I believe that Avingtrans’ management is excellent and will deliver significant shareholder value. |
Overlaying the asset type breakdown illustrated in Figure 1, is a deliberate bias towards dividend paying stocks. My rationale for this is as follows. As mentioned in the “Background” above I need to draw an income from my portfolio. Theoretically an income could be produced from a pure capital growth portfolio by simply selling the requisite number of shares each month. This is fine in a bull market, but when the market generally declines, you would be forced to sell more shares at the worst time – when preferably you would want to add to holdings, taking advantage of lower prices (as I did in March this year).
I made the assumption that dividends were more stable/reliable than share prices, so could be relied upon to produce the necessary income, irrespective of market/share price behaviour. The events of March caused me to question that assumption – and whether I should be more “dividend agnostic”, as company after company suspended or cut its dividend. This prompted me to investigate and led me to this report from Link. p6 of the Q2 Dividend Monitor includes this chart of UK dividend payouts since 2007:

I would have preferred to examine a longer term history but have been unable to find data going further back. I note from this chart that 2020 has been truly exceptional and in general my basic assumption holds true. Even during the financial crisis dividends only fell modestly. The extraordinary conditions of the pandemic have forced many companies to preserve cash and suspend their dividends, but I expect “normal service to be resumed” once the pandemic has been conquered. It is hard to imagine another economic event that would have as big an impact on dividend payouts as a “once in a century” pandemic. Therefore I do not propose to alter my dividend bias significantly – but may allow high performing capital growers (like HVPE) to become a slightly larger proportion of my portfolio.
I hope I haven’t bored you too much with this monster article, but doing the analysis was at least informative for me!
I wish my readers happy investing in 2021 and happier times as this dreadful pandemic, hopefully, fades into history. Stay safe!
Mark Bentley, Director, ShareSoc
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Enter your email to sign up as a free Associate ShareSoc member and receive our emails. It takes a few seconds — and on the next page you'll have the option to customise your membership.
Fascinating review of your portfolio during 2020, Mark. Thanks for sharing the information.
great read, thanks for taking the time to share.
Wow, I clearly have a lot to still learn thankbyou
Fascinating and illuminating. Thanks
Interesting article. Overall performance seems to be similar to mine – see: https://roliscon.blog/2021/01/04/year-end-review-better-than-expected/
Thank you very much for this. Very helpful and interesting!
Perhaps all investors should undertake such an annual review, for the lessons to be learnt from the past year and as a guide to the next. Thank you.